Trends in Cardiovascular Medicine
Volume 15, Issue 7 , Pages 249-253 , October 2005

Cardiomyocyte-Specific Overexpression of Nitric Oxide Synthase 3: Impact on Left Ventricular Function and Myocardial Infarction

  • Kenneth D. Bloch

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Kenneth D. Bloch, MD, Cardiovascular Research Center, CNY4, Massachusetts General Hospital, 149 13th St, Charlestown, MA 02129. Tel.: (+1) 617-724-9540; fax: (+1) 617-726-5806.
    • ,
  • Stefan Janssens

References 

  1. Barouch LA, et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature. 2002;416:337–339
  2. Bendall JK, et al. Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat. Circulation. 2004;110:2368–2375
  3. Brunner F, et al. Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Circulation. 2001;104:3097–3102
  4. Brunner F, et al. Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Cardiovasc Res. 2003;57:55–62
  5. Champion HC, et al. Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3. Circ Res. 2004;94:657–663
  6. Cooke JP. NO and angiogenesis. Atheroscler Suppl. 2003;4:53–60
  7. Damy T, et al. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet. 2004;363:1365–1367
  8. Hare JM, Stamler JS. NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest. 2005;115:509–517
  9. Hou J, et al. Angiotensin II-induced cardiac fibrosis in the rat is increased by chronic inhibition of nitric oxide synthase. J Clin Invest. 1995;96:2469–2477
  10. Huang PL, et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239–242
  11. Ichinose F, et al. Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency. Am J Physiol. 2004;286:H1070–H1075
  12. Janssens S, et al. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circ Res. 2004;94:1256–1262
  13. Jessup M, Brozena S. Heart failure. N Engl J Med. 2003;348:2007–2018
  14. Jones SP, et al. Myocardial ischemia–reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am J Physiol. 1999;276:H1567–H1573
  15. Jones SP, et al. Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice. Proc Natl Acad Sci U S A. 2003;100:4891–4896
  16. Jones SP, et al. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Am J Physiol. 2004;286:H276–H282
  17. Kempf T, Wollert KC. Nitric oxide and the enigma of cardiac hypertrophy. Bioessays. 2004;26:608–615
  18. Kim YM, Bombeck CA, Billiar TR. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res. 1999;84:253–256
  19. Landmesser U, et al. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation. 2004;110:1933–1939
  20. Liu YH, et al. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure. Hypertension. 2002;39:375–381
  21. Massion PB, Feron O, Dessy C, Balligand JL. Nitric oxide and cardiac function: Ten years after, and continuing. Circ Res. 2003;93:388–398
  22. Massion PB, et al. Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction. Circulation. 2004;110:2666–2672
  23. Ohashi Y, et al. Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J Clin Invest. 1998;102:2061–2071
  24. Ozaki M, et al. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J Clin Invest. 2002;110:331–340
  25. Ozaki M, et al. Overexpression of endothelial nitric oxide synthase attenuates cardiac hypertrophy induced by chronic isoproterenol infusion. Circ J. 2002;66:851–856
  26. Ruetten H, et al. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload. Cardiovasc Res. 2005;66:444–453
  27. Scherrer-Crosbie M, et al. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation. 2001;104:1286–1291
  28. Takimoto E, et al. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest. 2005;115:1221–1231
  29. Van Haperen R, et al. Reduction of blood pressure, plasma cholesterol, and atherosclerosis by elevated endothelial nitric oxide. J Biol Chem. 2002;277:48803–48807
  30. Vila-Petroff MG, et al. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res. 1999;84:1020–1031
  31. Yang XP, et al. Endothelial nitric oxide gene knockout mice: Cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury. Hypertension. 1999;34:24–30

PII: S1050-1738(05)00125-8

doi: 10.1016/j.tcm.2005.07.005

Trends in Cardiovascular Medicine
Volume 15, Issue 7 , Pages 249-253 , October 2005

Article Tools

* Image Usage & Resolution